![High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation | Bone Marrow Transplantation High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-019-0661-7/MediaObjects/41409_2019_661_Fig1_HTML.png)
High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation | Bone Marrow Transplantation
![Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial ... Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/93f2ccb3-4c96-4ada-93ff-a657e75fa75c/gr1.jpg)
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial ...
![Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium - European Journal of Cancer Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/64e44c51-dbbf-4353-ad13-05682ba1efe1/gr1_lrg.jpg)
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium - European Journal of Cancer
![ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe - Annals of Oncology ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/25d1266f-b21a-420c-9adf-39e9fa7ff7ed/gr1_lrg.jpg)
ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe - Annals of Oncology
![Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/56fd62e3-0de4-4c00-ada7-67a7e574f4d0/gr1a.jpg)